We’re a Team with a Common Mission

Picture of Robert Bowden

Robert Bowden

Picture of Robert Bowden

Robert Bowden

Prior to joining QLS Advisors, Rob was finishing his Ph.D. in Computer Science at Harvard University. For his dissertation, he expanded on ideas from the field of natural language processing and applied them to computer program repair, developing new representations and algorithms for machine learning on source code. His research culminated in a tool that is able to automatically debug introductory programming assignments and provide students with directed feedback to fix their code. Prior to his Ph.D., he received his B.A. and M.A. in Computer Science from Harvard University.

>

Picture of Shomesh Chaudhuri

Shomesh E. Chaudhuri

Picture of Shomesh Chaudhuri

Shomesh E. Chaudhuri

Prior to QLS, Dr. Chaudhuri was a postdoctoral associate at MIT’s Sloan School of Management where he helped design new funding vehicles and business models to access previously untapped pools of capital to support biomedical innovation. He has published articles in top finance and biotech journals including JAMA Oncology, Drug Discovery Today, and Management Science. His research includes simulating the financial performance of securitized biomedical research, designing clinical trials using Bayesian decision analysis, and building machine learning models for predicting drug approvals. He received a B.S. in biomedical engineering from Harvard University, and an M.S. and Ph.D. in electrical engineering and computer science from MIT.

<>

Picture of John Frishkopf

John Frishkopf

Picture of John Frishkopf

John Frishkopf

Prior to QLS, John Frishkopf was a founder of NewStar Financial, Inc. As the Treasurer and Head of Asset Management he developed NewStar’s risk management and securitization platform, issuing pioneering middle market collateralized loan obligations. Before NewStar, Mr. Frishkopf co-founded Benson Oak, a boutique investment bank focused on innovative international debt capital markets solutions for clients. Mr. Frishkopf has participated in research applying asset securitization techniques to drug development since 2013 and is a member of the board of directors of the National Brain Tumor Society as well as the Global Coalition for Adaptive Research, the sponsor of an adaptive clinical trial for glioblastoma. He holds a B.S. from the Massachusetts Institute of Technology and an M.M.S. from the MIT Sloan School of Management.

<>

Picture of Peter Hancock

Peter Hancock

Picture of Peter Hancock

Peter Hancock

Peter Hancock is the Former President and CEO of AIG. Prior to leading AIG, Mr. Hancock spent 20 years at J.P. Morgan where he founded the global derivatives business, restructured and ran the fixed income and credit businesses and served as group CFO and Chief Risk Officer. After J.P. Morgan, Mr. Hancock co-founded Integrated Finance Limited, where he served as President for seven years, and then served as Vice Chairman of Keycorp. He currently serves as an advisory board member to a Canadian VC fund. He holds a BA in politics, philosophy and economics from Oxford University.

<>

Picture of Andrew Lo

Andrew W. Lo

Picture of Andrew Lo

Andrew W. Lo

Andrew W. Lo is the Charles E. and Susan T. Harris Professor at the MIT Sloan School of Management, director of MIT’s Laboratory for Financial Engineering, and principal investigator at MIT’s Computer Science and Artificial Intelligence Laboratory. His healthcare-related research interests include new financial and business models for drug and device development and healthcare delivery, statistical methods for incorporating patient preferences into the drug approval process, and predicting clinical trial outcomes via machine learning techniques. He is a co-founder and director of BridgeBio Pharma, a director of Roivant Sciences, and a member of the NIH/NCATS advisory board and the American Cancer Society’s BrightEdge Impact Fund. Dr. Lo received his B.A. in economics from Yale University and his A.M. and Ph.D. in economics from Harvard University.

<>

Picture of Robert Merton

Robert C. Merton

Picture of Robert Merton

Robert C. Merton

Robert C. Merton is the School of Management Distinguished Professor of Finance at the MIT Sloan School of Management and John and Natty McArthur University Professor Emeritus at Harvard University. Merton’s research focuses on finance theory, including lifecycle and retirement finance, optimal portfolio selection, capital asset pricing, pricing of derivative securities, credit risk, loan guarantees, financial innovation, the dynamics of institutional change, and improving the methods of measuring and managing macro-financial risk. In 1997, Merton received the Alfred Nobel Memorial Prize in Economic Sciences in 1997 for a new method to determine the value of derivatives. He is past president of the American Finance Association, a member of the National Academy of Sciences, and a Fellow of the American Academy of Arts and Sciences. Merton received a B.S. in Engineering Mathematics from Columbia University, a M.S. in Applied Mathematics from California Institute of Technology and a Ph.D. in Economics from Massachusetts Institute of Technology and holds honorary degrees from nineteen universities.

<>

Photo of Michael Goldberg

Michael Goldberg

Photo of Michael Goldberg

Michael Goldberg

Michael Goldberg is Founder and CEO of STIMIT. Previously, he was a member of the faculty at Harvard Medical School and Dana-Farber Cancer Institute. Dr. Goldberg’s research has been published in Cell, Nature, Science, Nature Biotechnology, and Science Translational Medicine. Dr. Goldberg received his Hon. B.Sc. in Biological Chemistry from the University of Toronto, his M.Phil. in BioScience Enterprise from the University of Cambridge, and his Ph.D. in Biological Chemistry from the Massachusetts Institute of Technology (MIT), where he also completed his post-doctoral training.

<>

Photo of Richard Thakor

Richard T. Thakor

Photo of Richard Thakor

Richard T. Thakor

Richard T. Thakor is an Assistant Professor of Finance at University of Minnesota, Carlson School of Management. He is also a Research Affiliate at the MIT. Laboratory for Financial Engineering (LFE). He joined the finance department at University of Minnesota after earning his PhD in Financial Economics from MIT. He also holds an M.S. in Management Research from MIT, an MSc in Finance and Economics from the London School of Economics (LSE), and a B.A. (summa cum laude) in Economics and Psychology from Washington University in St. Louis. Prior to earning his PhD, he worked in investment management as a Derivatives Trading Analyst. His research consists of empirical and theoretical work in the areas of corporate finance, financial institutions, R&D investments, healthcare finance, and the economics of the drug development industry.

<

Join Us

Interested in reshaping the healthcare industry? We want to meet you! 

careers@qlsadvisors.com